skip to content

Boulos, Shahira Shawky

CPSO#: 78383

MEMBER STATUS
Active Member as of 30 Jul 2002
CURRENT OR PAST CPSO REGISTRATION CLASS
Restricted as of 07 Mar 2019

Summary

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui. Vivamus suscipit tortor eget felis porttitor volutpat. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Curabitur aliquet quam id dui posuere blandit. Vivamus suscipit tortor eget felis porttitor volutpat. Curabitur arcu erat, accumsan id imperdiet et, porttitor at sem. Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui. Donec sollicitudin molestie malesuada. Pellentesque in ipsum id orci porta dapibus.

Former Name: No Former Name

Gender: Female

Languages Spoken: Arabic, English

Education: Asyut University, 1986

Practice Information

Primary Location of Practice
490 Harry walker parkway south
Newmarket ON  L3Y 0B3
Phone: 905-868-8000 Electoral District: 05

Professional Corporation Information


Corporation Name: Dr. Shahira Boulos Medicine Professional Corporation
Certificate of Authorization Status: Inactive: Mar 17 2021
Corporation Name: Dr Boulos Medicine Professional Corporation
Certificate of Authorization Status: Inactive: Mar 15 2024
 

Medical Records Location

Instructions/Address:
RSRS
111 St. Regis Crescent South
Toronto ON  M3J 1Y6
Tel: 1-888-563-3732 ext. 1
Date Received: 07 Mar 2017

Specialties

Specialty Issued On Type
Family Medicine Effective:10 Jun 2002 CFPC Specialist

Registration History

Action Issue Date
First certificate of registration issued: Independent Practice Certificate Effective: 30 Jul 2002
Transfer of class of certificate to: Restricted certificate Effective: 07 Mar 2019
Terms and conditions imposed on certificate by member Effective: 07 Mar 2019

Practice Restrictions

Imposed By Effective Date Expiry Date Status
member Effective: 07 Mar 2019 Active
             As from March 7, 2019, the following is imposed as terms, conditions and
            limitations on the certificate of registration held by Dr. Shahira Shawky
            Boulos  in accordance with an undertaking and consent given by Dr. Boulos to
            the College of Physicians and Surgeons of Ontario:


                        UNDERTAKING, ACKNOWLEDGEMENT AND CONSENT
                                          ("Undertaking")
                  
                                                of
                  
                                    DR.  SHAHIRA SHAWKY BOULOS
                                          ("Dr. Boulos")
                  
                                                to
                  
                        COLLEGE OF PHYSICIANS AND SURGEONS OF ONTARIO
                                          (the "College")
                  
                  
                  
                  
            A.    PREAMBLE

            (1)   In this Undertaking:

                  "Code" means the Health Professions Procedural Code, which is Schedule 2
                  to the Regulated Health Professions Act, 1991, S.O. 1991, c. 18, as
                  amended; 
                  
                  "NMS" means the Drug Program Services Branch, the Narcotics Monitoring
                  System implemented under the Narcotics Safety and Awareness Act, 2010,
                  S.O. 2010, c. 22, as amended;
                  
                  "OHIP" means the Ontario Health Insurance Plan;
                  
                  "Public Register" means the College's register that is available to the
                  public.
                  
            (2)   I, Dr. Boulos, certificate of registration number 78383, am a member of
                  the College.  

            (3)   I, Dr. Boulos, acknowledge that following an investigation that raised
                  concerns about my prescribing of narcotics and controlled substances, I
                  underwent remediation and submitted to a reassessment. The reassessment
                  report received by the College raised concerns about my standard of
                  practice in prescribing of narcotics and controlled substances. However,
                  I subsequently provided the College with independent expert opinion which
                  was entirely supportive of my standards of practice.

            (4)   Further, I, Dr. Boulos, subsequently changed my scope of practice to
                  aesthetic medicine.

            B.    UNDERTAKING

            (5)   I, Dr. Boulos, undertake to abide by the provisions of this Undertaking,
                  effective immediately.

            (6)   Practice Restriction

                  (a)   I, Dr. Boulos, undertake to restrict my practice to aesthetic
                        medicine.  
            (7)   Resignation of Prescribing Privileges   

                  (a)   I, Dr. Boulos, undertake that I will not issue new prescriptions or
                        renew existing prescriptions for or administer any of the following
                        substances:
                  
                        (i)   Narcotic Drugs (from the Narcotic Control Regulations made
                              under the Controlled Drugs and Substances Act, S.C., 1996, c.
                              19);
                        (ii)  Narcotic Preparations (from the Narcotic Control Regulations
                              made under the Controlled Drugs and Substances Act, S.C.,
                              1996, c. 19);
                        (iii) Controlled Drugs (from Part G of the Food and Drug
                              Regulations under the Food and Drugs Act, S.C., 1985, c.
                              F-27); 
                        (iv)  Benzodiazepines and Other Targeted Substances (from the
                              Benzodiazepines and Other Targeted Substances Regulations
                              made under the Controlled Drugs and Substances Act., S.C.,
                              1996, c. 19); 
                  
                        (A summary of the above-named drugs [from Appendix I to the
                        Compendium of Pharmaceuticals and Specialties] is attached hereto
                        as Schedule "B"; and the current regulatory lists are attached
                        hereto as Schedule "C")
                  
                        (v)   All other Monitored Drugs (as defined under the Narcotics
                              Safety and Awareness Act, 2010, S.O. 2010, c. 22 as noted in
                              Schedule "D");                       
                  
                        and as amended from time to time. 
                  
            (8)   I, Dr. Boulos, acknowledge that I have executed the Prescribing
                  Resignation Letter to Health Canada, which is attached hereto as Schedule
                  "A" (the "Resignation Letter").

            (9)   I, Dr. Boulos, consent to the College sending the Resignation Letter to
                  Health Canada on my behalf.

            (10)  I, Dr. Boulos, undertake that I will return any supplies of the
                  substances referred to in section (7)(a) above that are presently in my
                  possession, in any place, to a pharmacy in a safe and secure manner, as
                  stipulated in the College's Policy Number 8-12, "Prescribing Drugs."

            (11)  I, Dr. Boulos, undertake to inform the College of each and every location
                  that I practise or have privileges, including, but not limited to, any
                  hospitals, clinics, offices, and any Independent Health Facilities with
                  which I am affiliated, in any jurisdiction (collectively my "Practice
                  Location" or "Practice Locations"), within five (5) days of executing
                  this Undertaking.  Going forward, I further undertake to inform the
                  College of any and all new Practice Locations within five (5) days of
                  commencing practice at that location.

            C.    ACKNOWLEDGEMENT

            (12)  I, Dr. Boulos, acknowledge that all schedules attached to or referred to
                  in this Undertaking form part of this Undertaking.

            (13)  I, Dr. Boulos, acknowledge and undertake that I shall be solely
                  responsible for payment of all fees, costs, charges, expenses, etc.
                  arising from the implementation of any of the provisions of this
                  Undertaking.

            (14)  I, Dr. Boulos, acknowledge that I have read and understand the provisions
                  of this Undertaking and that I have obtained independent legal counsel in
                  reviewing and executing this Undertaking, or have waived my right to do
                  so.

            (15)  I, Dr. Boulos, acknowledge that the College will provide this Undertaking
                  to any Chief of Staff, or a colleague with similar responsibilities, at
                  any Practice Location ("Chief of Staff" or "Chiefs of Staff").

            (16)  I, Dr. Boulos, acknowledge that a breach by me of any provision of this
                  Undertaking may constitute an act of professional misconduct and/or
                  incompetence, and may result in a referral of specified allegations to
                  the Discipline Committee.

            (17)  I, Dr. Boulos, acknowledge that this Undertaking constitutes terms,
                  conditions, and limitations on my certificate of registration for the
                  purposes of section 23 of the Code. 

            (18)  Public Register

                  (a)   I, Dr. Boulos, acknowledge that this Undertaking shall be posted on
                        the Public Register.
                  
                  (b)   I, Dr. Boulos, acknowledge that, in addition to this Undertaking
                        being posted in accordance with section (18)(a) above, the
                        following summary shall be posted on the Public Register:
                  
                        Following an investigation that raised concerns about Dr. Boulos'
                        prescribing of narcotics and controlled substances, she underwent
                        remediation and submitted to a reassessment. The reassessment
                        report received by the College raised concerns about her standards
                        of practice in the prescribing of narcotics and controlled
                        substances. However, she subsequently provided the College with
                        independent expert opinion which was entirely supportive of her
                        standards of practice.
                  
                        Further, she subsequently changed her scope of practice to
                        aesthetic medicine.
                  
                        Dr. Boulos has undertaken to restrict her practice to aesthetic
                        medicine.
                  
                        Dr. Boulos will not issue new prescriptions or renew existing
                        prescriptions for or administer any of the following substances:
                  
                        (i)   Narcotic Drugs (from the Narcotic Control Regulations made
                              under the Controlled Drugs and Substances Act, S.C., 1996, c.
                              19);
                        (ii)  Narcotic Preparations (from the Narcotic Control Regulations
                              made under the Controlled Drugs and Substances Act, S.C.,
                              1996, c. 19);
                        (iii) Controlled Drugs (from Part G of the Food and Drug
                              Regulations under the Food and Drugs Act, S.C., 1985, c.
                              F-27); 
                        (iv)  Benzodiazepines and Other Targeted Substances (from the
                              Benzodiazepines and Other Targeted Substances Regulations
                              made under the Controlled Drugs and Substances Act., S.C.,
                              1996, c. 19); 
                        (v)   All other Monitored Drugs (as defined under the Narcotics
                              Safety and Awareness Act, 2010, S.O. 2010, c. 22);        
                  
                              and as amended from time to time.
                  
            D.    CONSENT

            (19)  I, Dr. Boulos, undertake that I will submit to, and not interfere with,
                  unannounced inspections of my Practice Locations and patient charts by
                  the College and to any other activity the College deems necessary in
                  order to monitor my compliance with the provisions of this Undertaking.

            (20)  I, Dr. Boulos, give my irrevocable consent to the College to make
                  appropriate enquiries of OHIP, NMS, and any person who or institution
                  that may have relevant information, in order for the College to monitor
                  my compliance with the provisions of this Undertaking.

            (21)  I, Dr. Boulos, acknowledge that I have executed the OHIP and NMS consent
                  forms, attached hereto as Schedule "E" and Schedule "F", respectively.

            (22)  I, Dr. Boulos, give my irrevocable consent to the College to provide all
                  Chiefs of Staff with any information the College has that led to the
                  circumstances of my entering into this Undertaking and any information
                  arising from the monitoring of my compliance with this Undertaking.

Concerns

Source: Member
Active Date: March 7, 2019
Expiry Date:
Summary:
Summary of the Undertaking given by Dr. Shahira Shawky Boulos to the College of Physicians and Surgeons of Ontario, effective March 7, 2019:

Following an investigation that raised concerns about Dr. Boulos’ prescribing of narcotics and controlled substances, she underwent remediation and submitted to a reassessment. The reassessment report received by the College raised concerns about her standards of practice in the prescribing of narcotics and controlled substances. However, she subsequently provided the College with independent expert opinion which was entirely supportive of her standards of practice.

Further, she subsequently changed her scope of practice to aesthetic medicine.

Dr. Boulos has undertaken to restrict her practice to aesthetic medicine.

Dr. Boulos will not issue new prescriptions or renew existing prescriptions for or administer any of the following substances:

(i) Narcotic Drugs (from the Narcotic Control Regulations made under the Controlled Drugs and Substances Act, S.C., 1996, c. 19);

(ii) Narcotic Preparations (from the Narcotic Control Regulations made under the Controlled Drugs and Substances Act, S.C., 1996, c. 19);

(iii) Controlled Drugs (from Part G of the Food and Drug Regulations under the Food and Drugs Act, S.C., 1985, c. F-27);

(iv) Benzodiazepines and Other Targeted Substances (from the Benzodiazepines and Other Targeted Substances Regulations made under the Controlled Drugs and Substances Act., S.C., 1996, c. 19);

(v) All other Monitored Drugs (as defined under the Narcotics Safety and Awareness Act, 2010, S.O. 2010, c. 22);
and as amended from time to time.

CPSO will be closed on March 29, 2024. We will re-open on Monday, April 1, 2024, at 8:00 am.